Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sun Pharmaceutical Industries is the fourth-largest specialty generic pharmaceutical company globally and the largest pharmaceutical company in India. The company provides high-quality, affordable medicines trusted by healthcare professionals and patients in over 100 countries. Sun Pharma's business is supported by over 40 manufacturing facilities across six continents and a robust R&D infrastructure focused on complex generics and specialty products. Its specialty portfolio includes innovative treatments in dermatology, ophthalmology, and oncology, with key brands such as Ilumya, Cequa, and Winlevi. The company continues to expand its global footprint through strategic acquisitions and a deep pipeline of specialty and generic drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sun City Industries.